Novavax says its vaccine is 89.3% effective in UK trial

Novavax says its vaccine is 89.3% effective in UK trial

Novavax Inc said on Thursday its coronavirus vaccine was 89.3% effective in preventing COVID-19 in a trial conducted in the United Kingdom, and was nearly as effective in protecting against the more highly contagious variant first discovered in the UK, according to a preliminary analysis.


Category : Uncategorized

Read Also:

Latest MMM Article